Name:
IMPALA-2
Description:
Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) (IMPALA-2)
Stage:
Ongoing, closed to recuitment
Principal Investigator:
Professor Cormac McCarthy
Sponsor:
Savara Inc
Network Partners
